Modulatory effects of verapamil in rifampicin activity against Mycobacterium tuberculosis

被引：10
|
作者：
Caleffi-Ferracioli, Katiany R. [1 ]
Cardoso, Rosilene F. [1 ]
de Souza, Joao V. P. [1 ]
Murase, Leticia S. [1 ]
Canezin, Pedro H. [1 ]
Scodro, Regiane B. L. [1 ]
Siqueira, Vera L. D. [1 ]
Pavan, Fernando R. [2 ]
机构：
[1] Univ Estadual Maringa, Dept Clin Anal & Biomed, Lab Med Bacteriol, Maringa, Parana, Brazil
[2] Univ Estadual Paulista, Sch Pharmaceut Sci, Dept Biol Sci, Sao Paulo, Brazil
来源：
FUTURE MICROBIOLOGY | 2019年 / 14卷 / 03期
基金：
巴西圣保罗研究基金会;
关键词：
efflux pump inhibitor; gene regulation; multidrug transporters; Mycobacterium tuberculosis; real-time PCR; resistance; rifampicin; synergism; tuberculosis; verapamil; ABC EFFLUX PUMP; DRUG-RESISTANCE; GENE-EXPRESSION; MECHANISMS; MUTATIONS;
D O I：
10.2217/fmb-2018-0277
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Aim: To evaluate modulatory effect of verapamil (VP) in rifampicin (RIF) activity and its effect in efflux pumps (EPs) transcript levels in Mycobacterium tuberculosis. Materials & methods: RIF and VP minimal inhibitory concentration, combinatory effect and detection of mutations were determined in 16 isolates. EPs transcript levels were determined in four isolates by real-time PCR after exposure to drugs. Results: VP showed good combinatory effect among RIF-resistant isolates. This effect was also observed in the relative transcript levels of EPs, mainly after 72h of exposure, depending on the EP gene, genotype and the resistance profile of the isolate. Conclusion: Additional regulatory mechanisms in the EP activities, as well as, interactions with other drug-specific resistance mechanisms need further investigation in M. tuberculosis.
引用
收藏
页码：185 / 194
页数：10
相关论文
共 50 条
  • [41] Natural Terpenes Influence the Activity of Antibiotics against Isolated Mycobacterium tuberculosis
    Sieniawska, Elwira
    Swatko-Ossor, Marta
    Sawicki, Rafal
    Skalicka-Wozniak, Krystyna
    Ginalska, Grazyna
    MEDICAL PRINCIPLES AND PRACTICE, 2017, 26 (02) : 108 - 112
  • [42] Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages
    Viljoen, Albertus
    Raynaud, Clement
    Johansen, Matt D.
    Roquet-Baneres, Francoise
    Herrmann, Jean-Louis
    Daher, Wassim
    Kremer, Laurent
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (09)
  • [43] Effects of Increasing Concentrations of Rifampicin on Different Mycobacterium tuberculosis Lineages in a Whole-Blood Bactericidal Activity Assay
    Verma, Rupangi
    Gurumurthy, Meera
    Yeo, Benjamin Chaik Meng
    Lu, Qingshu
    Naftalin, Claire M.
    Paton, Nicholas, I
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (02)
  • [44] Multimetallic Microparticles Increase the Potency of Rifampicin against Intracellular Mycobacterium tuberculosis
    Ellis, Timothy
    Chiappi, Michele
    Garcia-Trenco, Andres
    Al-Ejji, Maryam
    Sarkar, Srijata
    Georgiou, Theoni K.
    Shaffer, Milo S. P.
    Tetley, Teresa D.
    Schwander, Stephan
    Ryan, Mary P.
    Porter, Alexandra E.
    ACS NANO, 2018, 12 (06) : 5228 - 5240
  • [45] Antifolate Activity of Plant Polyphenols against Mycobacterium tuberculosis
    Raju, Archana
    Degani, Mariam S.
    Khambete, Mihir P.
    Ray, M. K.
    Rajan, M. G. R.
    PHYTOTHERAPY RESEARCH, 2015, 29 (10) : 1646 - 1651
  • [46] Genome-wide SNP and InDel mutations in Mycobacterium tuberculosis associated with rifampicin and isoniazid resistance
    Li, Haicheng
    Guo, Huixin
    Chen, Tao
    Yu, Li
    Chen, Yuhui
    Zhao, Jiao
    Yan, Huimin
    Chen, Mu
    Sun, Qi
    Zhang, Chenchen
    Zhou, Lin
    Chen, Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (08): : 3903 - +
  • [47] Analysis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis isolates in Morocco using GenoType® MTBDRplus assay
    Ennassiri, Wifak
    Jaouhari, Sanae
    Sabouni, Radia
    Cherki, Wafa
    Charof, Reda
    Filali-Maltouf, Abdelkarim
    Lahlou, Ouafae
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 12 : 197 - 201
  • [48] Characterization of Mutations Causing Rifampicin and Isoniazid Resistance of Mycobacterium tuberculosis in Syria
    Madania, Ammar
    Habous, Maya
    Zarzour, Hana
    Ghoury, Ifad
    Hebbo, Barea
    POLISH JOURNAL OF MICROBIOLOGY, 2012, 61 (01) : 23 - 32
  • [49] Insight about cell wall remodulation triggered by rifampicin in Mycobacterium tuberculosis
    Meneguello, Jean Eduardo
    Arita, Glaucia Sayuri
    de Oliveira Silva, Joao Vitor
    Ghiraldi-Lopes, Luciana Dias
    Caleffi-Ferracioli, Katiany Rizzieri
    Dias Siqueira, Vera Lucia
    de Lima Scodro, Regiane Bertin
    Pilau, Eduardo Jorge
    Zannetti Campanerut-Sa, Paula Aline
    Cardoso, Rosilene Fressatti
    TUBERCULOSIS, 2020, 120
  • [50] Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-centre study
    Bahraminia, F.
    Zangiabadian, M.
    Nasiri, M. J.
    Fattahi, M.
    Goudarzi, M.
    Ranjbar, R.
    Fooladi, A. A. Imani
    NEW MICROBES AND NEW INFECTIONS, 2021, 42
12345